APOE and Alzheimer disease: In both SCD and MCI/AD, APOE ɛ4 carriers showed higher entorhinal tau PET BPND than noncarriers (P = 0.01 and P = 0.03, respectively) but not in other ROIs (Supplemental Table 2; Supplemental Fig. 2).